Ranibizumab Intraocular and Revonto Injection
Determining the interaction of Ranibizumab Intraocular and Revonto Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: dantrolene
Brand name: Dantrium, Revonto, Dantrium Intravenous, Ryanodex
Synonyms: Revonto
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Rexaphenac
- Ranibizumab Intraocular-Rexulti
- Ranibizumab Intraocular-Reyataz
- Ranibizumab Intraocular-Reyataz (Atazanavir Capsules)
- Ranibizumab Intraocular-Reyataz (Atazanavir Powder for Oral Suspension)
- Ranibizumab Intraocular-Reyvow
- Revonto Injection-Ranibizumab ophthalmic
- Revonto Injection-Ranitidine
- Revonto Injection-Ranitidine Capsule
- Revonto Injection-Ranitidine Hydrochloride
- Revonto Injection-Ranitidine Injection
- Revonto Injection-Ranitidine Suspension